Pfizer plans to test coronavirus vaccine booster engineered

Pfizer plans to test coronavirus vaccine booster engineered for South African variant
Phil Dormitzer, one of Pfizer's top viral vaccine scientists, said in an interview that he believes the current vaccine is highly likely to still protect against the concerning variant first discovered in South Africa
Reuters | February 19, 2021 | Updated 10:59 IST
A top Pfizer Inc scientist said on Thursday the company is in intensive discussions with regulators to test a booster shot version of its coronavirus vaccine specifically targeted for a highly contagious variant that is spreading widely in South Africa and elsewhere. Phil Dormitzer, one of Pfizer's top viral vaccine scientists, said in an interview that he believes the current vaccine - developed with Germany's BioNTech SE - is highly likely to still protect against the concerning variant first discovered in South Africa.

Related Keywords

South Africa , South African , Phil Dormitzer , Pfizer Vaccines Research , Pfizer , Pfizer Inc , Drug Administration , Coronavirus Vaccine , Covid 19 Vaccine , Pfizer Coronavirus Vaccine , Coronavirus Vaccine South African Variant , South African Variant Of Coronavirus , South African Covid 19 Variant , South African Coronavirus Variant , Pfizer Coronavirus Vaccine South African Varian , ஃபைசர் தடுப்பு மருந்துகள் ஆராய்ச்சி , ஃபைசர் , ஃபைசர் இன்க் ,